Phase Ii study of idarubicin in advanced endometrial carcinoma
Hakes, T.B.; Raymond, V.
Cancer Treatment Reports 71(5): 535-536
1987
ISSN/ISBN: 0361-5960 PMID: 3471330 Document Number: 292829
Document emailed within 1 workday
Related Documents
Lionetto, R.; Pronzato, P.; Conte, P.F.; Sertoli, M.R.; Amoroso, D.; Rosso, R. 1986: Idarubicin in advanced breast cancer: a phase II study Cancer Treatment Reports 70(12): 1439-1440Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1993: Early phase Ii study of Idarubicin, a new anthracycline anticancer drug, in acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(7): 897-906
Masaoka, T.; Ogawa, M.; Yamada, K.; Kimura, K.; Ohhashi, Y. 1993: A late phase Ii comparative study of idarubicin + cytarabine and daunorubicin + cytarabine in adult patients with acute non-lymphocytic leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(13): 1995-2005
Stehman, F.B.; Blessing, J.A.; Delgado, G.; Louka, M. 1983: Phase Ii evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study Cancer Treatment Reports 67(7-8): 737-738
Fujita, H.; Ogawa, M.; Masaoka, T.; Yamada, K.; Kimura, K. 1992: A pharmacokinetic study of idarubicin hydrochloride, a new anthracycline anti-tumor drug, in patients with acute leukemia. Idarubicin Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(6): 791-798
Vogel, S.J.; Presant, C.A.; Ratkin, G.A.; Klahr, C. 1979: Phase i study of thymidine plus 5-fluorouracil infusions in advanced colorectal carcinoma Cancer Treatment Reports 63(1): 1-5
Shah, M.K.; St Marie, K.; Catalano, R.B.; Dierks, K.; Creech, R.H. 1985: Phase Ii study of 5-day infusion of vinblastine in patients with advanced ovarian carcinoma Cancer Treatment Reports 69(2): 229-230
Scotto, V.; Sbiroli, C. 1991: Weekly cis-platinum as third line chemotherapy in advanced ovarian carcinoma. Phase Ii study European Journal of Gynaecological Oncology 12(1): 51-53
Horvath, G.; Stendahl, U.; Kalling, M.; Fernö, M.; Himmelmann, A.; Hajba, A. 1990: Antiestrogenic treatment of advanced and recurrent carcinoma corporis uteri--a phase Ii study of toremifene Anticancer Research 10(2a): 323-325
Kunisaki, C.; Imada, T.; Yamada, R.; Hatori, S.; Ono, H.; Otsuka, Y.; Matsuda, G.; Nomura, M.; Akiyama, H.; Kubo, A.; Shimada, H. 2005: Phase II study of docetaxel plus cisplatin as a second-line combined therapy in patients with advanced gastric carcinoma Anticancer Research 25(4): 2973-2977
Schulman, P.; Davis, R.B.; Rafla, S.; Green, M.; Henderson, E. 1984: Phase Ii trial of spirogermanium in advanced renal cell carcinoma: a Cancer and Leukemia Group B study Cancer Treatment Reports 68(10): 1305-1306
Takezako, Y.; Okusaka, T.; Ueno, H.; Ikeda, M.; Morizane, C.; Najima, M. 2008: Phase Ii study of cisplatin, epirubicin and continuous infusion of 5-fluorouracil in patients with advanced intrahepatic cholangiocellular carcinoma (ICC) Hepato-Gastroenterology 55(85): 1380-1384
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Li, Q.-S.; Li, D.-P.; Wu, X.-R.; Sheng, X.-G.; Zhang, X.-L.; Song, Q.-Q. 2009: Surgical treatment in advanced endometrial carcinoma Zhonghua Fu Chan Ke Za Zhi 44(10): 750-753
1973: Megestrol acetate (Megace) and other progestins in advanced endometrial carcinoma Medical Letter on Drugs and Therapeutics 15(6): 27-28
Edmonson, J.H.; Krook, J.E.; Hilton, J.F.; Long, H.J.; Cullinan, S.A.; Everson, L.K.; Malkasian, G.D. 1986: Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatment Cancer Treatment Reports 70(8): 1019-1020
Pujade-Lauraine, E.; Guastalla, J.P.; Weber, B.; Curé, H.; Orfeuvre, H.; Mousseau, M.; Vincent, P.; Diéras, V.; Tubiana-Mathieu, N.; Jacquin, J.P.; Mignot, L.; Leduc, B.; Paraïso, D.; Viens, P. 1997: Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase Ii study Seminars in Oncology 24(5 Suppl 15: S15
Stendahl, U.; Wagenius, G.; Strang, P.; Tribukait, B. 1988: Flow cytometry in invasive endometrial carcinoma. Correlations between DNA content S-phase rate and clinical parameters In Vivo 2(2): 123-127
Foggi, P.; Amodio, A. 2003: Molecular therapy of breast carcinoma in the advanced phase Tumori 89(4 Suppl): 189-191
Hausknecht, R.U.; Gusberg, S.B. 1969: Estrogen metabolism in patients at high risk for endometrial carcinoma. I. Urinary metabolites of H3-estradiol in normal postmenopausal women and those with endometrial carcinoma American Journal of Obstetrics and Gynecology 105(8): 1161-1167